Shortened Modified Look-Locker Inversion recovery (ShMOLLI) for clinical myocardial T1-mapping at 1.5 and 3 T within a 9 heartbeat breathhold

被引:530
作者
Piechnik, Stefan K. [1 ]
Ferreira, Vanessa M. [1 ,2 ]
Dall'Armellina, Erica [1 ]
Cochlin, Lowri E. [3 ]
Greiser, Andreas [4 ]
Neubauer, Stefan [1 ]
Robson, Matthew D. [1 ]
机构
[1] Univ Oxford, John Radcliffe Hosp, Ctr Clin Magnet Resonance Res OCMR, Dept Cardiovasc Med, Oxford OX3 9DU, England
[2] Univ Calgary, Stephenson CMR Ctr, Libin Cardiovasc Inst Alberta, Calgary, AB, Canada
[3] Univ Oxford, Dept Physiol Anat & Genet, Oxford OX3 9DU, England
[4] Siemens AG, Healthcare Sector, D-8520 Erlangen, Germany
关键词
MAGNETIC-RESONANCE; T-1; INFARCTION; RESOLUTION; MOLLI;
D O I
10.1186/1532-429X-12-69
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Background: T1 mapping allows direct in-vivo quantitation of microscopic changes in the myocardium, providing new diagnostic insights into cardiac disease. Existing methods require long breath holds that are demanding for many cardiac patients. In this work we propose and validate a novel, clinically applicable, pulse sequence for myocardial T1-mapping that is compatible with typical limits for end-expiration breath-holding in patients. Materials and methods: The Shortened MOdified Look-Locker Inversion recovery (ShMOLLI) method uses sequential inversion recovery measurements within a single short breath-hold. Full recovery of the longitudinal magnetisation between sequential inversion pulses is not achieved, but conditional interpretation of samples for reconstruction of T1-maps is used to yield accurate measurements, and this algorithm is implemented directly on the scanner. We performed computer simulations for 100 ms<T1 < 2.7 s and heart rates 40-100 bpm followed by phantom validation at 1.5T and 3T. In-vivo myocardial T1-mapping using this method and the previous gold-standard (MOLLI) was performed in 10 healthy volunteers at 1.5T and 3T, 4 volunteers with contrast injection at 1.5T, and 4 patients with recent myocardial infarction (MI) at 3T. Results: We found good agreement between the average ShMOLLI and MOLLI estimates for T1 < 1200 ms. In contrast to the original method, ShMOLLI showed no dependence on heart rates for long T1 values, with estimates characterized by a constant 4% underestimation for T1 = 800-2700 ms. In-vivo, ShMOLLI measurements required 9.0 +/- 1.1 s (MOLLI = 17.6 +/- 2.9 s). Average healthy myocardial T1 s by ShMOLLI at 1.5T were 966 +/- 48 ms (mean +/- SD) and 1166 +/- 60 ms at 3T. In MI patients, the T1 in unaffected myocardium (1216 +/- 42 ms) was similar to controls at 3T. Ischemically injured myocardium showed increased T1 = 1432 +/- 33 ms (p < 0.001). The difference between MI and remote myocardium was estimated 15% larger by ShMOLLI than MOLLI (p < 0.04) which suffers from heart rate dependencies for long T1. The in-vivo variability within ShMOLLI T1-maps was only 14% (1.5T) or 18% (3T) higher than the MOLLI maps, but the MOLLI acquisitions were twice longer than ShMOLLI acquisitions. Conclusion: ShMOLLI is an efficient method that generates immediate, high-resolution myocardial T1-maps in a short breath-hold with high precision. This technique provides a valuable clinically applicable tool for myocardial tissue characterisation.
引用
收藏
页数:11
相关论文
共 20 条
[1]
MYOCARDIAL INVOLVEMENT IN SYSTEMIC LUPUS-ERYTHEMATOSUS DETECTED BY MAGNETIC-RESONANCE IMAGING [J].
BEEN, M ;
THOMSON, BJ ;
SMITH, MA ;
RIDGWAY, JP ;
DOUGLAS, RHB ;
BEEN, M ;
BEST, JJK ;
MUIR, AL .
EUROPEAN HEART JOURNAL, 1988, 9 (11) :1250-1256
[2]
BEEN M, 1985, LANCET, V2, P348
[3]
BOTTOMLEY PA, 1984, MED PHYS, V11, P425, DOI 10.1118/1.595535
[4]
Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart - A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association [J].
Cerqueira, MD ;
Weissman, NJ ;
Dilsizian, V ;
Jacobs, AK ;
Kaul, S ;
Laskey, WK ;
Pennell, DJ ;
Rumberger, JA ;
Ryan, T ;
Verani, MS .
CIRCULATION, 2002, 105 (04) :539-542
[5]
Cochlin L., 2003, P INT SOC MAGNETIC R, V11, P885
[6]
Evaluation of Diffuse Myocardial Fibrosis in Heart Failure With Cardiac Magnetic Resonance Contrast-Enhanced T1 Mapping [J].
Iles, Leah ;
Pfluger, Heinz ;
Phrommintikul, Arintaya ;
Cherayath, Joshi ;
Aksit, Pelin ;
Gupta, Sandeep N. ;
Kaye, David M. ;
Taylor, Andrew J. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 52 (19) :1574-1580
[7]
The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. [J].
Kim, RJ ;
Wu, E ;
Rafael, A ;
Chen, EL ;
Parker, MA ;
Simonetti, O ;
Klocke, FJ ;
Bonow, RO ;
Judd, RM .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (20) :1445-1453
[8]
Cardiovascular Magnetic Resonance and prognosis in cardiac amyloidosis [J].
Maceira, Alicia M. ;
Prasad, Sanjay K. ;
Hawkins, Philip N. ;
Roughton, Michael ;
Pennell, Dudley J. .
JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE, 2008, 10 (1)
[9]
Maceira AM, 2005, CIRCULATION, V111, P186, DOI 10.1161/01.CIR.0000152819.97857.9D
[10]
Breath-holding in healthy and pulmonary-compromised populations: Effects of hyperventilation and oxygen inspiration [J].
Marks, B ;
Mitchell, DG ;
Simelaro, JP .
JOURNAL OF MAGNETIC RESONANCE IMAGING, 1997, 7 (03) :595-597